Recorded 97 million yen as fair value decrease on investment securities and 22 million yen as impairment on fixed assets as special losses. These have been included in the Q3 2026 consolidated quarterly earnings release, and there is no impact on the full-year consolidated earnings guidance.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"3653","jir_company_name":"Morpho, Inc.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-09-11","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/09\/3653-20260911-03.pdf","jir_short_summary":"Recorded 97 million yen as fair value decrease on investment securities and 22 million yen as impairment on fixed assets as special losses. These have been included in the Q3 2026 consolidated quarterly earnings release, and there is no impact on the full-year consolidated earnings guidance.","jir_summary":"### Performance overview\nIn the consolidated results for the third quarter of the fiscal year ending October 2026, the company recorded special losses for fair value decreases on investment securities and impairment of fixed assets. The fair value decrease on investment securities amounted to 97 million yen due to a decline in stock prices, and impairment of fixed assets was 22 million yen considering recoverable amounts. These have been disclosed in the earnings release published today, and there is no impact on the full-year earnings outlook.\n\n### Outlook and impact\nThe impact amount from the recording of these special losses does not meet the criteria to revise earnings guidance under timely disclosure rules, so there is no change to the full-year consolidated earnings forecast disclosed on June 12, 2026. The company will maintain its stance to preserve financial soundness while pursuing structural reforms.","jir_financial_highlights":"Investment securities fair value decrease: 97 \u767e\u4e07\u5186 (Unknown)\nImpairment of fixed assets: 22 \u767e\u4e07\u5186 (Unknown)","jir_category":"","jir_hashtags":"#Morpho, #SpecialLossRecorded, #Earnings","jir_key_figures":"Investment securities fair value decrease: 97 \u767e\u4e07\u5186\uff08special loss\uff09\nImpairment of fixed assets: 22 \u767e\u4e07\u5186\uff08special loss\uff09\nCurrent full-year consolidated earnings forecast: unchanged","jir_meta_title":"\u3010Morpho\u3011Notice of Special Loss Recording | 3Q FY2026 (October 2026)","jir_meta_description":"Morpho, Inc. records a special loss of 97 million yen on investment securities fair value and 22 million yen impairment of fixed assets in the Q3 FY2026 earnings release. No impact on full-year earnings guidance.","jir_og_title":"Morpho | Notice of Special Loss Recording (3Q FY2026)","jir_og_description":"Morpho records a special loss in the third quarter. Investment securities fair value decrease of 97 million yen, impairment of fixed assets 22 million yen. Full-year guidance unchanged.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":60155,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-112880","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n